DE69004290D1 - Pharmazeutische Zusammensetzung, die ein Hydantoin-Derivat enthält. - Google Patents

Pharmazeutische Zusammensetzung, die ein Hydantoin-Derivat enthält.

Info

Publication number
DE69004290D1
DE69004290D1 DE90103279T DE69004290T DE69004290D1 DE 69004290 D1 DE69004290 D1 DE 69004290D1 DE 90103279 T DE90103279 T DE 90103279T DE 69004290 T DE69004290 T DE 69004290T DE 69004290 D1 DE69004290 D1 DE 69004290D1
Authority
DE
Germany
Prior art keywords
hydantoin derivative
pharmaceutical composition
composition
composition containing
high molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90103279T
Other languages
English (en)
Other versions
DE69004290T2 (de
Inventor
Masayasu Kurono
Makoto Sato
Shigeaki Yoshina
Yoshiya Kondo
Tsuneaki Inoue
Akiharu Inoue
Kiichi Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2026139A external-priority patent/JP2688266B2/ja
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Publication of DE69004290D1 publication Critical patent/DE69004290D1/de
Application granted granted Critical
Publication of DE69004290T2 publication Critical patent/DE69004290T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69004290T 1989-02-22 1990-02-20 Pharmazeutische Zusammensetzung, die ein Hydantoin-Derivat enthält. Expired - Fee Related DE69004290T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4274389 1989-02-22
JP5869489 1989-03-10
JP2026139A JP2688266B2 (ja) 1989-02-22 1990-02-07 アルドース還元酵素阻害作用を有し且つ吸収性の良好な薬剤組成物

Publications (2)

Publication Number Publication Date
DE69004290D1 true DE69004290D1 (de) 1993-12-09
DE69004290T2 DE69004290T2 (de) 1994-05-26

Family

ID=27285280

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69004290T Expired - Fee Related DE69004290T2 (de) 1989-02-22 1990-02-20 Pharmazeutische Zusammensetzung, die ein Hydantoin-Derivat enthält.

Country Status (10)

Country Link
EP (1) EP0384416B1 (de)
AT (1) ATE96668T1 (de)
AU (1) AU627843B2 (de)
CA (1) CA2021923C (de)
DE (1) DE69004290T2 (de)
DK (1) DK0384416T3 (de)
ES (1) ES2062125T3 (de)
FI (1) FI93694C (de)
NZ (1) NZ232619A (de)
WO (1) WO1990009791A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03215435A (ja) * 1990-01-12 1991-09-20 Sanwa Kagaku Kenkyusho Co Ltd アルドース還元酵素阻害剤を主成分とする潰瘍治療剤
JPH0784481B1 (de) * 1991-02-21 1995-09-13
CA2349098C (en) * 2000-05-30 2011-03-01 Integrated Biomedical Technology, Inc. Assay for aldehyde content

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
EP0264586B1 (de) * 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin-Derivate zur Behandlung von Komplikationen bei Diabetes
DE3670570D1 (de) * 1986-09-02 1990-05-31 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Also Published As

Publication number Publication date
DK0384416T3 (da) 1994-02-28
AU627843B2 (en) 1992-09-03
FI93694B (fi) 1995-02-15
CA2021923C (en) 1998-04-28
ATE96668T1 (de) 1993-11-15
NZ232619A (en) 1992-06-25
WO1990009791A1 (en) 1990-09-07
CA2021923A1 (en) 1990-08-23
EP0384416B1 (de) 1993-11-03
ES2062125T3 (es) 1994-12-16
FI93694C (fi) 1995-05-26
AU5107690A (en) 1990-09-26
FI905179A0 (fi) 1990-10-19
DE69004290T2 (de) 1994-05-26
EP0384416A1 (de) 1990-08-29

Similar Documents

Publication Publication Date Title
DE68901417D1 (de) Pharmazeutische zusammensetzung.
UA49799C2 (uk) Циклопептиди, спосіб їх одержання, фармацевтична композиція, що їх містить, спосіб її одержання, спосіб боротьби з захворюваннями, спосіб одержання іммобілізованих лігандів
NO870241L (no) Hypoglykemiske tiazolidindioner.
ATE151764T1 (de) Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
EP0026464A3 (de) Peptide, deren Herstellung, deren Verwendung und pharmazeutische Präparate
NO884892L (no) Fremgangsmaate til innkapsling eller omdanning til fast stoff av et materiale med vandig kontinuerlig fase.
AU6889196A (en) Long active composition for rectal administration
DE69004290T2 (de) Pharmazeutische Zusammensetzung, die ein Hydantoin-Derivat enthält.
PT91612A (pt) Process for the preparation pf 2-aza-4(alkoxycarbonyl> spiro<4,5> decan-3-on and of his own acid derivative 1-(aminomethyl)-cyclo-hexane-acetic
DE3873011T2 (de) Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
EA199700095A1 (ru) Фармацевтическая композиция для парентерального введения, содержащая индолкарбоновую кислоту
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ATE80797T1 (de) Hemizellulosematrix enthaltende arzneizubereitungen mit verzoegerter freisetzung.
DE3886950D1 (de) Platin-verbindungen, geeignet zur verwendung als arzneimittel.
DE69104608T2 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
EP0384364A3 (de) Zusammensetzung von nichtlinearen Materialien und Verfahren zur Herstellung
DE3881254D1 (de) Pharmazeutische zusammensetzung.
ATE817T1 (de) 2-(1-phenyl-2,5-cyclohexa dienyl)-aethylaminderivate, verfahren zu deren herstellung, deren verwendung als pharmazeutische wirkstoffe sowie diese enthaltende arzneimittel.
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
NO900061D0 (no) Fremgangsmaate til hindring av stempelringrotasjon.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee